In this review:
This narrative review summarizes some important aspects of the clinical use of dolutegravir (Tivicay), which is an orally-administered integrase strand transfer inhibitor (INSTI) that is approved for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents in adults and adolescents.
Download PDF